Results 31 to 40 of about 7,517 (258)
Transfusion, 2023 Extracorporeal photopheresis (ECP) treatment, mostly based on apheresis technology, is used for immunomodulation in various diseases such as cutaneous T‐cell lymphoma, graft versus host disease and other (auto)immune disorders.
W. Mayer +8 more
semanticscholar +1 more source
Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing [PDF]
, 2016 Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease.
Compernolle, Veerle +7 more
core +2 more sources
Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023 Extracorporeal photopheresis (ECP) has gained importance in the treatment of several diseases. Initially introduced as a new therapeutic modality for the treatment of patients with cutaneous T‐cell lymphoma, the indications for the use of ECP have ...
A. Cho, Verena Paulitschke, R. Knobler
semanticscholar +1 more source
Advances in extracorporeal photopheresis
Zhongguo shuxue zazhi, 2022 Extracorporeal photopheresis(ECP) is a bidirectional cellular immunomodulatory therapy based on leukapheresis, which can mediate not only immunopotentiation but also immunosuppression.
Zhanrui CHENG +3 more
doaj +1 more source
Severe overlap of morphea and lichen sclerosus after anti-PD-L1 immunotherapy in small cell lung cancer. [PDF]
J Dtsch Dermatol GesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 3, Page 378-380, March 2025.
Geidel G +7 more
europepmc +2 more sources
Extracorporeal photopheresis: how, why and for whom?
Pediatric Hematology/Oncology and Immunopathology, 2023 Extracorporeal photopheresis is a method of cell therapy that was developed and introduced into clinical practice of various specialties over 30 years ago but its mechanism of action, clinical application and the possibility of further modification ...
I. Kumukova, P. Trakhtman, E. Kurnikova
semanticscholar +1 more source
Journal of clinical apheresis, 2023 Extracorporeal photopheresis (ECP) is considered an effective treatment for patients with chronic graft vs host disease (cGVHD) and demonstrates efficacy in ameliorating GVHD.
I. Goldberg +11 more
semanticscholar +1 more source
OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
Вестник трансплантологии и искусственных органов, 2018 Aim – to perform a comparative study of the long-term results of the combined use of extracorporeal photochemotherapy (photopheresis) and drug immunosuppression and standard immunosuppressive therapy in patients after kidney transplantation.Materials and
A. P. Faenko +6 more
doaj +1 more source
A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease [PDF]
, 2017 Although significant advances have been made in the biologic understanding of graft-versus-host disease (GVHD) and its treatment options, GVHD remains the single most challenging obstacle to the success of allogeneic hematopoietic cell transplantation ...
Kharfan-Dabaja, Mohamed +2 more
core +3 more sources
Alʹmanah Kliničeskoj Mediciny, 2016 Urogenital reactive arthritis (Reiter's disease) is a vital interdisciplinary problem due to multiple symptoms of the disease, their appearance at different times, inadequate clinical alertness of specialist, as well as to the necessity of significant ...
A. V. Molochkov, M. S. Petrova
doaj +1 more source